by Michael Doe | Sep 2, 2021 | Free Press Releases
The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed...
by Michael Doe | Sep 2, 2021 | Free Press Releases
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots...
by Michael Doe | Aug 26, 2021 | Free Press Releases
Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions Roots Analysis is pleased to...
by Michael Doe | Aug 26, 2021 | Free Press Releases
Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers London Roots Analysis has...
by Michael Doe | Aug 19, 2021 | Free Press Releases
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers Roots Analysis is pleased to announce the publication of its recent study, titled,...
